Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 9, 2025
Temporal Changes in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use in Patients with Chronic Kidney Disease and Type 2 Diabetes, 2012-2023: A US Cohort StudyCatherine B Johannes, Craig I Coleman, Csaba P Kovesdy, et al.
Drug Safety|February 19, 2021
Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of PrucaloprideAna Ruigómez, Estel Plana, Alicia Gilsenan, et al.
British Journal of Haematology|January 6, 2016
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern eraLoretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Pharmacotherapy|May 4, 2018
Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort StudyAlejandro Arana, Andrea V Margulis, Lisa J McQuay, et al.
Leukemia & Lymphoma|September 30, 2014
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United StatesLoretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Current Medical Research and Opinion|May 25, 2019
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancerRamaswamy Govindan, Suresh Senan, Nicolas Dickgreber, et al.
Drug Safety|December 17, 2022
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World SettingCatherine B Johannes, Daniel C Beachler, J Bradley Layton, et al.
Drug Safety|December 30, 2022
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World SettingHeather E Danysh, Catherine B Johannes, Daniel C Beachler, et al.
Drug Safety|May 29, 2019
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350Joan Fortuny, Alicia Gilsenan, Miguel Cainzos-Achirica, et al.
Open Forum Infectious Diseases|April 13, 2026
mRNA and Protein Subunit COVID-19 Vaccine Reactogenicity and Their Relationship to Productivity for Healthcare Workers and First RespondersSarang K Yoon, Andrew L Phillips, Sarah Calhoun, et al.
Pageof 3